Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piero O Bonetti

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of the American College of Cardiology|July 27, 2002
Simvastatin preserves myocardial perfusion and coronary microvascular permeability in experimental hypercholesterolemia independent of lipid loweringPiero O Bonetti, Stephanie H Wilson, Martin Rodriguez-Porcel, et al.
Circulation|May 29, 2003
Coronary endothelial dysfunction is associated with an increased risk of cerebrovascular eventsPaul V Targonski, Piero O Bonetti, Geralyn M Pumper, et al.
Journal of the American College of Cardiology|December 8, 2004
Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemiaPiero O Bonetti, Geralyn M Pumper, Stuart T Higano, et al.
Swiss Medical Weekly|May 31, 2011
Incidence of acute myocardial infarction after implementation of a public smoking ban in Graubünden, Switzerland: two year follow-upPiero O Bonetti, Lukas D Trachsel, Max U Kuhn, et al.
Atherosclerosis|June 13, 2003
Endothelin type A receptor antagonism restores myocardial perfusion response to adenosine in experimental hypercholesterolemiaPiero O Bonetti, Patricia J M Best, Martin Rodriguez-Porcel, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|April 12, 2005
Long-term benefits and limitations of combined antianginal drug therapy in elderly patients with symptomatic chronic coronary artery diseasePiero O Bonetti, Christoph Kaiser, Michael J Zellweger, et al.
Neurobiology of Aging|May 17, 2005
Bosentan preserves endothelial function in mice overexpressing APPAhmad A Elesber, Piero O Bonetti, Julie E Woodrum, et al.
The American Journal of Cardiology|July 16, 2005
Influence of revascularization on long-term outcome in patients > or =75 years of age with diabetes mellitus and angina pectorisRaban V Jeger, Piero O Bonetti, Michael J Zellweger, et al.
Cardiology|June 27, 2008
Drug-eluting stents compared with bare metal stents improve late outcome after saphenous vein graft but not after large native vessel interventionsRaban V Jeger, Stefan Schneiter, Christoph Kaiser, et al.
Lancet (London, England)|September 13, 2005
Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitäts Trial (BASKET)Christoph Kaiser, Hans Peter Brunner-La Rocca, Peter T Buser, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of the American College of Cardiology|July 27, 2002
Simvastatin preserves myocardial perfusion and coronary microvascular permeability in experimental hypercholesterolemia independent of lipid loweringPiero O Bonetti, Stephanie H Wilson, Martin Rodriguez-Porcel, et al.
Circulation|May 29, 2003
Coronary endothelial dysfunction is associated with an increased risk of cerebrovascular eventsPaul V Targonski, Piero O Bonetti, Geralyn M Pumper, et al.
Journal of the American College of Cardiology|December 8, 2004
Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemiaPiero O Bonetti, Geralyn M Pumper, Stuart T Higano, et al.
Swiss Medical Weekly|May 31, 2011
Incidence of acute myocardial infarction after implementation of a public smoking ban in Graubünden, Switzerland: two year follow-upPiero O Bonetti, Lukas D Trachsel, Max U Kuhn, et al.
Atherosclerosis|June 13, 2003
Endothelin type A receptor antagonism restores myocardial perfusion response to adenosine in experimental hypercholesterolemiaPiero O Bonetti, Patricia J M Best, Martin Rodriguez-Porcel, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|April 12, 2005
Long-term benefits and limitations of combined antianginal drug therapy in elderly patients with symptomatic chronic coronary artery diseasePiero O Bonetti, Christoph Kaiser, Michael J Zellweger, et al.
Neurobiology of Aging|May 17, 2005
Bosentan preserves endothelial function in mice overexpressing APPAhmad A Elesber, Piero O Bonetti, Julie E Woodrum, et al.
The American Journal of Cardiology|July 16, 2005
Influence of revascularization on long-term outcome in patients > or =75 years of age with diabetes mellitus and angina pectorisRaban V Jeger, Piero O Bonetti, Michael J Zellweger, et al.
Cardiology|June 27, 2008
Drug-eluting stents compared with bare metal stents improve late outcome after saphenous vein graft but not after large native vessel interventionsRaban V Jeger, Stefan Schneiter, Christoph Kaiser, et al.
Lancet (London, England)|September 13, 2005
Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitäts Trial (BASKET)Christoph Kaiser, Hans Peter Brunner-La Rocca, Peter T Buser, et al.
Pageof 3